Dapagliflozin, an inhibitor of SGLT2 as an adjunct to diet and exercise, is being investigated to evaluate its safety and its efficacy on blood sugar levels in adults with type 2 diabetes….

Although the pharmacokinetics and pharmacodynamics of high-dose human regular U-500 and human regular U-100 insulin are similar, the U-500 formulation may have a longer duration of action.…

Erectile dysfunction has traditionally been associated with vascular problems, but men with severe peripheral neuropathy frequently reported ED as well as failure with phosphodiesterase type-5 inhibitors.…

State bans on sugar-sweetened drinks in middle schools didn’t have much impact on kids’ overall consumption.…

Have you ever had a patient who is a pre-school child with diabetes? Usually this means that the parents are trying to stay in control and the child wants more independence. In this issue’s Clinical Gem, we focus on the battles that everyone faces during this time and why they occur. …

Edited by Frank J. Snoek and T. Chas Skinner Treatment Issues for Children Under 6 Years of Age   Once diagnosed, the basic goals of diabetes therapy for children under the age of 6 years are similar to those recommended to all children and adolescents and include the avoidance of …

This week, we wrap up our seven part series of Homerun Slides on Incretins with a discussion of Incretin Therapy and Type 2 Diabetes Mellitus…

This week we are headlining the break-up of the Lilly-Amylin alliance and how that might affect the anticipated sales of the hopefully soon-to-be-approved Bydureon. Most of us found it hard to believe that after all this time that Lilly would give up on the exenatide franchise but when you examine …

If your diabetes patients have sleep apnea, they may also have hypertension…. Link to download (.ppt format): Sleep Apnea Check out all of Diabetes In Control’s slide collections at our new Clinical Presentations Library.

Lilly and Amylin Agree to End Partnership See this week’s Item #3, Lilly and Amylin Agree to End Diabetes Alliance.